I get the feeling SB is giving serious consideration to going straight to Stage 2 with the initial construction of the processing plant, or he should be.
No skilled forecasters usually look further than 10 years, and let's face it, we have enough reserves for that already, I'm fairly certain of that.
So could it be the market is thinking along the same lines and believes we are likely to be processing say 300,000tpa+ for 10 years - around 60% of what PLS are aiming for (460,000 to 510,000dmt)?
PLS are a $6.3bn MC company right now.
We'd therefore have to be looking at a $2bn MC and ASX200 listing once we're producing then.
And I think the Govt is going to seriously push to get a Lithium Hydroxide plant going up in Darwin too. If it further backs CXO to get that going over the next 3-4 years, then another major re-rate will be coming.
So much to look forward to. At this rate I'll not want to ever sell any!
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-4854
-
- There are more pages in this discussion • 34,144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 40442 | 0.135 |
4 | 35803 | 0.130 |
7 | 139927 | 0.125 |
25 | 692305 | 0.120 |
35 | 2189293 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 196393 | 4 |
0.125 | 1736447 | 26 |
0.130 | 1337414 | 32 |
0.135 | 1219517 | 20 |
0.140 | 888488 | 11 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online